Literature DB >> 22607016

Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice.

Anthony E Dragun1, Bin Huang, Thomas C Tucker, William J Spanos.   

Abstract

First-line surgical options for early stage breast cancer and ductal carcinoma in situ include breast conserving surgery or mastectomy. We analyzed factors that influence the receipt of mastectomy and resultant trends over time. Registry analysis was carried out for 21,869 women who underwent up-front surgical treatment for stage 0, I or II breast cancer between 1998 and 2007 using data from the Kentucky Cancer Registry. We examined the trend of treatment over time and assessed the probability of receiving mastectomy using multivariate logistic regression. Overall, 54.5% of women received breast conservation and 45.5% received mastectomy over a 10-year period (annual BCS rate range: 46.9-61.2%). The overall mastectomy rate substantially decreased from 53.1% in 1998 to 38.8% in 2005 (p < 0.0001), but then increased to 45% in 2007 (p < 0.001). Between 2005 and 2007, the increase in mastectomies in the age groups of <50 years, 50-69 years, and ≥ 70 years was 7.5% (p = 0.0351), 4.9% (p = 0.0132) and, 8.0% (p = 0.0283), respectively. On multivariate analysis, the rate of receiving mastectomy was drastically higher for women with stage I or II (versus in situ) disease and moderate or poorly differentiated (versus well differentiated) histology. The rate was modestly higher for uninsured and government-insured (versus privately insured) patients, patients older than 70 years (versus younger), rural (versus urban) location, receptor negative (versus receptor positive) disease, and unusual histologies (versus ductal and lobular histology). There was no statistically significant difference in surgical choice with regard to race. Determinants of mastectomy for in situ and early stage breast cancer include stage, histology, age, insurance status, county of residence, receptor status. The rate of mastectomy declined until 2005 and is now increasing across all age groups, especially for women < 50 years and ≥ 70 years.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22607016     DOI: 10.1111/j.1524-4741.2012.01245.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  37 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  A qualitative study of rural women's views for the treatment of early breast cancer.

Authors:  Eli Ristevski; Melanie Regan; David Birks; Nicole Steers; Anny Byrne
Journal:  Health Expect       Date:  2014-09-29       Impact factor: 3.377

Review 3.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

4.  Mastectomy technique using a self-designed self-retaining retractor system.

Authors:  Michael Co; Ava Kwong
Journal:  Surg Today       Date:  2016-07-27       Impact factor: 2.549

Review 5.  Risk-reducing mastectomy.

Authors:  Federica Chiesa; Virgilio S Sacchini
Journal:  Minerva Ginecol       Date:  2016-01-19

6.  Decision Regret following Treatment for Localized Breast Cancer: Is Regret Stable Over Time?

Authors:  Kathryn A Martinez; Yun Li; Ken Resnicow; John J Graff; Ann S Hamilton; Sarah T Hawley
Journal:  Med Decis Making       Date:  2014-12-22       Impact factor: 2.583

7.  Factors associated with patients in the Scottish Highlands who chose mastectomy when suitable for breast conservation.

Authors:  Rosalyn Shearer; Majid Rashid; Gill Hubbard; Nick Abbott; Ian Daltrey; Russell Mullen
Journal:  Gland Surg       Date:  2016-08

Review 8.  Breast cancer therapy-associated cardiovascular disease.

Authors:  Timothy M Zagar; Daniela M Cardinale; Lawrence B Marks
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

9.  Stem cell and tissue engineering in breast reconstruction.

Authors:  Tanasit Techanukul; Visnu Lohsiriwat
Journal:  Gland Surg       Date:  2014-02

10.  Cost and Complications of Local Therapies for Early-Stage Breast Cancer.

Authors:  Benjamin D Smith; Jing Jiang; Ya-ChenTina Shih; Sharon H Giordano; Jinhai Huo; Reshma Jagsi; Adeyiza O Momoh; Abigail S Caudle; Kelly K Hunt; Simona F Shaitelman; Thomas A Buchholz; Shervin M Shirvani
Journal:  J Natl Cancer Inst       Date:  2016-09-27       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.